Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Scientists have unveiled insights into how HIV-1, the virus responsible for AIDS, skillfully hijacks cellular machinery for its own survival. By dissecting the molecular interplay between the virus ...

Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

Coauthor Yamina Bennasser and her colleagues characterized a sequence in the HIV-1 genome that encodes a rare siRNA precursor ... In addition, they found that the virus prevents RNA silencing through ...

On left, the HIV virus binds to CD4 T cell CD4 receptor ... After reverse transcription, the proviral DNA is integrated into cellular genome and will synthesize viral precursor proteins and ...

HIV can linger in the body for a decade or longer before the onset of AIDS, so experts have conjectured that the virus arrived in the country years before it was recognized. But precisely when and ...

Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus ...

Because the AIDS-causing pathogen HIV integrates its genome into that of infected host cells, individuals cannot realistically be cleared of virus once infection is established. Thus, anti-HIV ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

HIV-1, like other viruses ... near the critical “frameshift site” in the viral genome. This frameshift site is essential for the virus to produce the correct proportions of two key proteins ...